Powered by Google

Sorry, something went wrong and the translator is not available.

Sorry, something went wrong with the translation request.

loading Translating

 
Maropitant Citrate (Cerenia)
Revised: September 18, 2024
Published: June 16, 2008

(For veterinary information only)

WARNING
The size of the tablet/medication is NOT an indication of a proper dose. Never administer any drug without your veterinarian's input. Serious side effects or death can occur if you use drugs on your pet without your veterinarian's advice. 

It is our policy not to give dosing information over the internet.

Brand Name: Cerenia

Available in 16 mg, 24 mg, 60 mg, and 160 mg tablets; and as injectable

How This Medication Works

The brain actually has an area called the vomit center, and when it is stimulated, vomiting happens. Stimulation can happen in several ways: over-filling the stomach, emotional shock, motion sickness or from activity in another brain area called the "chemoreceptor trigger zone" which in turn reacts to nauseating toxins in the bloodstream. These mechanisms are not isolated and can occur in combination.

Background

While strong nausea-controlling drugs in injectable form have been available for pets for some time, oral medications have been lacking. Until recently, efforts were largely confined to the oral use of metoclopramide (which is rather short-acting) and meclizine (which is not approved for use in pets). In 2008, Pfizer released maropitant citrate, a strong anti-nausea medication for dogs that could be given once a day. Maropitant has since been approved for cats as well.

The brain actually has an area called the vomit center, and when it is stimulated, vomiting happens. Stimulation can happen in several ways: over-filling the stomach, emotional shock, motion sickness, or activity in another brain area called the "chemoreceptor trigger zone," which in turn reacts to nauseating toxins in the bloodstream. These mechanisms are not isolated and can occur in combination.

An important molecular step in initiating vomiting involves the binding of a material called substance P to a structure called the NK-1 receptor. This lock-and-key binding occurs in both the vomit center and the chemoreceptor trigger zone. Maropitant citrate mimics the structure of substance P and binds the NK-1 receptors so that they cannot bind substance P, thus making stimulation of the vomit center extremely difficult.

Substance P is involved in numerous inflammatory conditions, so it has led to further investigation of maropitant citrate uses far beyond nausea control. It is currently being explored in the treatment of chronic upper respiratory infections in cats, cough suppression, feline idiopathic cystitis, and inflammatory bowel disease.

How This Medication Is Used

Maropitant is used once a day to control nausea. It can be given as an injection or as a tablet. The dose is higher for motion sickness than for treatment of disease-related nausea. Maropitant can be used short-term for acute nausea episodes or long-term for more chronic situations. 

Maropitant can also be used daily as a cough suppressant and fashioned into nose drops to control upper respiratory congestion.

Side Effects

Side effects are uncommon with this medication, but the most commonly noted side effect is vomiting up the pill immediately after giving it. Giving the medication with a small amount of food can lessen this. 

The FDA has received sporadic reports of more serious reactions: facial swelling, incoordination, fever, muscle tremors, and convulsions.

Interaction With Other Drugs

The risk of experiencing the above side effects is increased when maropitant is combined with other drugs that are high blood protein-bound in the circulation.

Common drugs that meet this criterion include non-steroidal anti-inflammatory drugs, sulfa-class antibiotics, as well as others. Some drugs use the same removal enzyme system as maropitant, and concurrent use can alter the removal of maropitant from the body. 

Such medications include cimetidine (antacid), erythromycin (antibiotic), ketoconazole (antifungal), itraconazole (antifungal), terbinafine (antifungal), fluoxetine (for behavior modification).

Concerns and Cautions

  • Note that the dosage recommended for a one-time control of motion sickness is much higher than that for longer-term nausea relief, as in the treatment of a disease.
  • Maropitant is approved for puppies over eight weeks of age and cats at least 16 weeks of age.
  • Do not give this medication wrapped in a treat that may upset your pet's stomach. Minimize fatty treats as they work against the effectiveness of the medication.
  • Maropitant may require dose adjustment for pets with liver disease.
  • Maropitant has not been evaluated in pregnant or nursing animals.
  • Store maropitant tablets in their blister packs at room temperature.
  • If a dose is accidentally skipped, simply give it when it is remembered. Do not double up on the next dose.

See more information from the manufacturer of Cerenia.

The content of this site is owned by Veterinary Information Network (VIN®), and its reproduction and distribution may only be done with VIN®'s express permission.

The information contained here is for general purposes only and is not a substitute for advice from your veterinarian. Any reliance you place on such information is strictly at your own risk.

Links to non-VIN websites do not imply a recommendation or endorsement by VIN® of the views or content contained within those sites.

Top
SAID=27